|
|
9610 Medical Center Drive, Suite 200 Rockville, MD 20850 USA phone:(1) 301 762 7776 fax:(1) 301 762 7778
|
|
| Symbol |
Private |
| Founded |
1997 |
| Employees |
|
|
|
| www.sequella.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Treatment of infectious diseases |
 |
| Management |
| Carol A. Nacy, Ph.D., Founder and Chief Executive Officer; Leo Einck, Ph.D., Founder and Chief Scientific Officer; Gary Horwith, M.D., Chief Medical Officer; Alan Klein, Executive Vice President, Corporate Development; Katherine Sacksteder, Ph.D., Vice President, Diagnostics |
| |
|
|
| |
|
| Keywords |
| infectious diseases, diagnosis, treatment, drug compliance monitor |
|
|
|
| Description |
|
Sequella develops products to improve diagnosis and treatment of infectious diseases that pose serious risk to public health and have both significant market opportunities and clear commercialization pathways. |
 |
 |
|
|
|
|
|
|